This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Small Business

Gilead Sciences Plunges for Second Day in a Row: What Wall Street's Saying

Gilead Sciences Plunges for Second Day in a Row: What Wall Street's Saying

The biotech stock's shares fell again Tuesday following the news of Express Scripts' exclusive deal with AbbVie. Here's what analysts said about Gilead.

12/23/14 - 01:48 PM EST

AbbVie's Exclusive Hepatitis C Deal With Express Scripts: What Wall Street's Saying

AbbVie strikes an exclusive deal with Express Scripts to exclusively distribute AbbVie's hepatitis C therapy. Here's what analysts said.

12/22/14 - 11:20 AM EST

7 Must-Read Business and Investing Books Coming Out This Week

7 Must-Read Business and Investing Books Coming Out This Week

  • Tickers in this article:
  • WLT

From Jim Cramer's Get Rick Carefully to Building a Business: The Jim Walter Story, here are seven books coming out this week that you must read.

12/27/14 - 08:51 AM EST

7 Best and Worst Chemical Stocks for the Era of Lower Oil Prices

7 Best and Worst Chemical Stocks for the Era of Lower Oil Prices

Click through to see which chemicals stocks made Morgan Stanley's list as either materially benefitting or being challenged from lower oil prices.

12/26/14 - 08:13 AM EST

Virgin America Surges on Bullish Comments: What Wall Street's Saying

Virgin America Surges on Bullish Comments: What Wall Street's Saying

  • Tickers in this article:
  • VA

Virgin America has surged nearly 70% from its IPO price in November. Here's what sell-side analysts are saying about the stock.

12/24/14 - 11:50 AM EST

Walgreen Shares Rise on Earnings Beat: What Wall Street's Saying

Walgreen Shares Rise on Earnings Beat: What Wall Street's Saying

  • Tickers in this article:
  • WAG

Walgreen's fiscal first-quarter earnings beat analysts' expectations, fueled by pharmacy sales growth. Here's what analysts said.

12/24/14 - 08:55 AM EST

Gilead Sciences Plunges for Second Day in a Row: What Wall Street's Saying

Gilead Sciences Plunges for Second Day in a Row: What Wall Street's Saying

The biotech stock's shares fell again Tuesday following the news of Express Scripts' exclusive deal with AbbVie. Here's what analysts said about Gilead.

12/23/14 - 01:48 PM EST

11 Best Small-Cap Technology Stocks That Could Hit It Big in 2015

11 Best Small-Cap Technology Stocks That Could Hit It Big in 2015

Which small technology companies could become the next Facebook, Google or Apple? Here are TheStreet Ratings' top picks for small-cap tech stocks.

12/23/14 - 08:41 AM EST

AbbVie's Exclusive Hepatitis C Deal With Express Scripts: What Wall Street's Saying

AbbVie's Exclusive Hepatitis C Deal With Express Scripts: What Wall Street's Saying

AbbVie strikes an exclusive deal with Express Scripts to exclusively distribute AbbVie's hepatitis C therapy. Here's what analysts said.

12/22/14 - 11:20 AM EST

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015

Which biotech and pharmaceuticals stocks should investors buy in 2015? JPMorgan named six companies with the best investment cases as part of its top U.S. stocks picks for 2015.

12/22/14 - 08:23 AM EST

13 Best Christmas Movies Ever and How Much They Made at the Box Office

13 Best Christmas Movies Ever and How Much They Made at the Box Office

  • Tickers in this article:
  • RENT

How much did your all-time favorite Christmas movie make at the box office? The answers could surprise you.

12/20/14 - 09:13 AM EST

4 Must-Read Business Books Out this Week That You Should Buy

4 Must-Read Business Books Out this Week That You Should Buy

Looking for a last-minute gift this week? A book from this week's new business book releases could be the perfect solution.

12/20/14 - 08:38 AM EST

Red Hat Shares Hit 52-Week High on Earnings: What Wall Street's Saying

Red Hat Shares Hit 52-Week High on Earnings: What Wall Street's Saying

  • Tickers in this article:
  • RHT

Shares of Red Hat, an open-source software company, surge on Friday after earnings for its latest fiscal quarter topped analysts' estimates. Here's what analysts said.

12/19/14 - 11:24 AM EST

Nike Falls on Soft Future Orders: What Wall Street's Saying

Nike Falls on Soft Future Orders: What Wall Street's Saying

  • Tickers in this article:
  • NKE

Nike shares tumble on Friday following Wall Street's concern that 'future orders' for the sneaker and apparel company's merchandise are slipping. Here's what analysts said.

12/19/14 - 10:09 AM EST

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs